People with obesity using semaglutide see cardiovascular improvements

Researchers analysing the utility of the weight loss drug semaglutide in treating people with obesity have found that weekly subcutaneous injections improve sustained weight reduction, as well as reduced instances of cardiovascular disease. The study was published in Nature Medicine.

News Medical